alexa Development and Validation of Derivative Spectroscopic


Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Development and Validation of Derivative Spectroscopic Method for the Simultaneous Estimation of Rosuvastatin Calcium and Fenofibrate in Tablet

 
To read the full article Peer-reviewed Article PDF image

Abstract

A simple, novel, sensitive and precise validated spectrophotometric method was developed for simultaneous determination of Rosuvastatin calcium and Fenofibrate in synthetic mixture and its dosage form. Methanol was selected as a common solvent for estimation of Rosuvastatin calcium (ROS) and Fenofibrate (FEN) with λmax at 243 nm and 224 nm respectively in methanol. The linearity was obtained in the concentration ranges of 4-12 μg/ml for Rosuvastatin and 16-48 μg/ml for Fenofibrate. The Zero Crossing Point (ZCP) of Rosuvastatin was 224.11 nm and Fenofibrate was 243.29 nm. The correlation coefficient for the ROS was 0.9963and for FEN 0.9996. The % RSD for intraday precision was 0.76-1.05 % for ROS and 0.32-1.16 % for FEN. The interday precision was 0.76-1.82 % and 0.42-1.47 % for ROS and FEN respectively. The detection limit and quantification limit were found to be 1.96 and 5.96 μg/ml for Rosuvastatin and 0.76 and 2.32 μg/ml for Fenofibrate respectively. All the validation parameter was perform as per the International Conference on Harmonization (ICH) guidelines. The recovery study was carried out, result were 100.9-103.2% for ROS and 100.9-101.3% for FEN. No interference form the tablet excipients showed the applicability of method to the routine analysis of the pharmaceutical dosage form.

Keywords

Recommended Journals

Share This Page

Additional Info

Loading
Loading Please wait..
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords